This long mixed-DL peptide contains a wide distribution of aromatic, polar, acidic, and basic residues that create highly diverse folding potential. Researchers examine its extended flexibility, β-turn formation, and intramolecular packing. The sequence supports mapping complex interaction networks and aggregation behavior. Its C-terminal amide enhances structural stability.
CAT No: R2500
CAS No:179986-95-9
Synonyms/Alias:FL108785;(Leu31,Pro34)-Peptide YY (human) trifluoroacetate salt;179986-95-9;H-Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg -Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Leu-Thr-A rg-Pro-Arg-Tyr-NH2; H-YPIKPEAPGEDASPEELNRYYASLRHYLNLLTRPRY-NH2;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.